1 Study Coverage
    1.1 Erythropoietin Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Erythropoietin Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Epoetin-alfa
        1.2.3 Darbepoetin-alfa
        1.2.4 Epoetin-beta
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Erythropoietin Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Anemia
        1.3.3 Kidney Disorders
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Erythropoietin Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Erythropoietin Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Erythropoietin Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Erythropoietin Drug Sales by Region
        2.4.1 Global Erythropoietin Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Erythropoietin Drug by Region (2023-2028)
    2.5 Global Erythropoietin Drug Revenue by Region
        2.5.1 Global Erythropoietin Drug Revenue by Region (2017-2022)
        2.5.2 Global Erythropoietin Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Erythropoietin Drug Sales by Manufacturers
        3.1.1 Global Top Erythropoietin Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Erythropoietin Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Erythropoietin Drug in 2021
    3.2 Global Erythropoietin Drug Revenue by Manufacturers
        3.2.1 Global Erythropoietin Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Erythropoietin Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Erythropoietin Drug Revenue in 2021
    3.3 Global Erythropoietin Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Erythropoietin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Erythropoietin Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Erythropoietin Drug Sales by Type
        4.1.1 Global Erythropoietin Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Erythropoietin Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Erythropoietin Drug Sales Market Share by Type (2017-2028)
    4.2 Global Erythropoietin Drug Revenue by Type
        4.2.1 Global Erythropoietin Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Erythropoietin Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Erythropoietin Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Erythropoietin Drug Price by Type
        4.3.1 Global Erythropoietin Drug Price by Type (2017-2022)
        4.3.2 Global Erythropoietin Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Erythropoietin Drug Sales by Application
        5.1.1 Global Erythropoietin Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Erythropoietin Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Erythropoietin Drug Sales Market Share by Application (2017-2028)
    5.2 Global Erythropoietin Drug Revenue by Application
        5.2.1 Global Erythropoietin Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Erythropoietin Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Erythropoietin Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Erythropoietin Drug Price by Application
        5.3.1 Global Erythropoietin Drug Price by Application (2017-2022)
        5.3.2 Global Erythropoietin Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Erythropoietin Drug Market Size by Type
        6.1.1 North America Erythropoietin Drug Sales by Type (2017-2028)
        6.1.2 North America Erythropoietin Drug Revenue by Type (2017-2028)
    6.2 North America Erythropoietin Drug Market Size by Application
        6.2.1 North America Erythropoietin Drug Sales by Application (2017-2028)
        6.2.2 North America Erythropoietin Drug Revenue by Application (2017-2028)
    6.3 North America Erythropoietin Drug Market Size by Country
        6.3.1 North America Erythropoietin Drug Sales by Country (2017-2028)
        6.3.2 North America Erythropoietin Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Erythropoietin Drug Market Size by Type
        7.1.1 Europe Erythropoietin Drug Sales by Type (2017-2028)
        7.1.2 Europe Erythropoietin Drug Revenue by Type (2017-2028)
    7.2 Europe Erythropoietin Drug Market Size by Application
        7.2.1 Europe Erythropoietin Drug Sales by Application (2017-2028)
        7.2.2 Europe Erythropoietin Drug Revenue by Application (2017-2028)
    7.3 Europe Erythropoietin Drug Market Size by Country
        7.3.1 Europe Erythropoietin Drug Sales by Country (2017-2028)
        7.3.2 Europe Erythropoietin Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Erythropoietin Drug Market Size by Type
        8.1.1 Asia Pacific Erythropoietin Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Erythropoietin Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Erythropoietin Drug Market Size by Application
        8.2.1 Asia Pacific Erythropoietin Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Erythropoietin Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Erythropoietin Drug Market Size by Region
        8.3.1 Asia Pacific Erythropoietin Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Erythropoietin Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Erythropoietin Drug Market Size by Type
        9.1.1 Latin America Erythropoietin Drug Sales by Type (2017-2028)
        9.1.2 Latin America Erythropoietin Drug Revenue by Type (2017-2028)
    9.2 Latin America Erythropoietin Drug Market Size by Application
        9.2.1 Latin America Erythropoietin Drug Sales by Application (2017-2028)
        9.2.2 Latin America Erythropoietin Drug Revenue by Application (2017-2028)
    9.3 Latin America Erythropoietin Drug Market Size by Country
        9.3.1 Latin America Erythropoietin Drug Sales by Country (2017-2028)
        9.3.2 Latin America Erythropoietin Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Erythropoietin Drug Market Size by Type
        10.1.1 Middle East and Africa Erythropoietin Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Erythropoietin Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Erythropoietin Drug Market Size by Application
        10.2.1 Middle East and Africa Erythropoietin Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Erythropoietin Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Erythropoietin Drug Market Size by Country
        10.3.1 Middle East and Africa Erythropoietin Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Erythropoietin Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Amgen
        11.1.1 Amgen Corporation Information
        11.1.2 Amgen Overview
        11.1.3 Amgen Erythropoietin Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Amgen Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Amgen Recent Developments
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Corporation Information
        11.2.2 Johnson & Johnson Overview
        11.2.3 Johnson & Johnson Erythropoietin Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Johnson & Johnson Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Johnson & Johnson Recent Developments
    11.3 Roche
        11.3.1 Roche Corporation Information
        11.3.2 Roche Overview
        11.3.3 Roche Erythropoietin Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Roche Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Roche Recent Developments
    11.4 Galenica
        11.4.1 Galenica Corporation Information
        11.4.2 Galenica Overview
        11.4.3 Galenica Erythropoietin Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Galenica Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Galenica Recent Developments
    11.5 Emcure
        11.5.1 Emcure Corporation Information
        11.5.2 Emcure Overview
        11.5.3 Emcure Erythropoietin Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Emcure Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Emcure Recent Developments
    11.6 Kyowa Hakko Kirin
        11.6.1 Kyowa Hakko Kirin Corporation Information
        11.6.2 Kyowa Hakko Kirin Overview
        11.6.3 Kyowa Hakko Kirin Erythropoietin Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Kyowa Hakko Kirin Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Kyowa Hakko Kirin Recent Developments
    11.7 3SBio
        11.7.1 3SBio Corporation Information
        11.7.2 3SBio Overview
        11.7.3 3SBio Erythropoietin Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 3SBio Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 3SBio Recent Developments
    11.8 Biocon
        11.8.1 Biocon Corporation Information
        11.8.2 Biocon Overview
        11.8.3 Biocon Erythropoietin Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Biocon Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Biocon Recent Developments
    11.9 LG Life Sciences
        11.9.1 LG Life Sciences Corporation Information
        11.9.2 LG Life Sciences Overview
        11.9.3 LG Life Sciences Erythropoietin Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 LG Life Sciences Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 LG Life Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Erythropoietin Drug Industry Chain Analysis
    12.2 Erythropoietin Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Erythropoietin Drug Production Mode & Process
    12.4 Erythropoietin Drug Sales and Marketing
        12.4.1 Erythropoietin Drug Sales Channels
        12.4.2 Erythropoietin Drug Distributors
    12.5 Erythropoietin Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Erythropoietin Drug Industry Trends
    13.2 Erythropoietin Drug Market Drivers
    13.3 Erythropoietin Drug Market Challenges
    13.4 Erythropoietin Drug Market Restraints
14 Key Findings in The Global Erythropoietin Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Erythropoietin Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Epoetin-alfa
    Table 3. Major Manufacturers of Darbepoetin-alfa
    Table 4. Major Manufacturers of Epoetin-beta
    Table 5. Major Manufacturers of Others
    Table 6. Global Erythropoietin Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Erythropoietin Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Erythropoietin Drug Sales by Region (2017-2022) & (K Units)
    Table 9. Global Erythropoietin Drug Sales Market Share by Region (2017-2022)
    Table 10. Global Erythropoietin Drug Sales by Region (2023-2028) & (K Units)
    Table 11. Global Erythropoietin Drug Sales Market Share by Region (2023-2028)
    Table 12. Global Erythropoietin Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Erythropoietin Drug Revenue Market Share by Region (2017-2022)
    Table 14. Global Erythropoietin Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Erythropoietin Drug Revenue Market Share by Region (2023-2028)
    Table 16. Global Erythropoietin Drug Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Erythropoietin Drug Sales Share by Manufacturers (2017-2022)
    Table 18. Global Erythropoietin Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Erythropoietin Drug Revenue Share by Manufacturers (2017-2022)
    Table 20. Erythropoietin Drug Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Erythropoietin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Erythropoietin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin Drug as of 2021)
    Table 23. Erythropoietin Drug Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Erythropoietin Drug Product Offered
    Table 25. Date of Manufacturers Enter into Erythropoietin Drug Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Erythropoietin Drug Sales by Type (2017-2022) & (K Units)
    Table 28. Global Erythropoietin Drug Sales by Type (2023-2028) & (K Units)
    Table 29. Global Erythropoietin Drug Sales Share by Type (2017-2022)
    Table 30. Global Erythropoietin Drug Sales Share by Type (2023-2028)
    Table 31. Global Erythropoietin Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Erythropoietin Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Erythropoietin Drug Revenue Share by Type (2017-2022)
    Table 34. Global Erythropoietin Drug Revenue Share by Type (2023-2028)
    Table 35. Erythropoietin Drug Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Erythropoietin Drug Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Erythropoietin Drug Sales by Application (2017-2022) & (K Units)
    Table 38. Global Erythropoietin Drug Sales by Application (2023-2028) & (K Units)
    Table 39. Global Erythropoietin Drug Sales Share by Application (2017-2022)
    Table 40. Global Erythropoietin Drug Sales Share by Application (2023-2028)
    Table 41. Global Erythropoietin Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Erythropoietin Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Erythropoietin Drug Revenue Share by Application (2017-2022)
    Table 44. Global Erythropoietin Drug Revenue Share by Application (2023-2028)
    Table 45. Erythropoietin Drug Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Erythropoietin Drug Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Erythropoietin Drug Sales by Type (2017-2022) & (K Units)
    Table 48. North America Erythropoietin Drug Sales by Type (2023-2028) & (K Units)
    Table 49. North America Erythropoietin Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Erythropoietin Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Erythropoietin Drug Sales by Application (2017-2022) & (K Units)
    Table 52. North America Erythropoietin Drug Sales by Application (2023-2028) & (K Units)
    Table 53. North America Erythropoietin Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Erythropoietin Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Erythropoietin Drug Sales by Country (2017-2022) & (K Units)
    Table 56. North America Erythropoietin Drug Sales by Country (2023-2028) & (K Units)
    Table 57. North America Erythropoietin Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Erythropoietin Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Erythropoietin Drug Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Erythropoietin Drug Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Erythropoietin Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Erythropoietin Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Erythropoietin Drug Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Erythropoietin Drug Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Erythropoietin Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Erythropoietin Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Erythropoietin Drug Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Erythropoietin Drug Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Erythropoietin Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Erythropoietin Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Erythropoietin Drug Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Erythropoietin Drug Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Erythropoietin Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Erythropoietin Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Erythropoietin Drug Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Erythropoietin Drug Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Erythropoietin Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Erythropoietin Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Erythropoietin Drug Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Erythropoietin Drug Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Erythropoietin Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Erythropoietin Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Erythropoietin Drug Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Erythropoietin Drug Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Erythropoietin Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Erythropoietin Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Erythropoietin Drug Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Erythropoietin Drug Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Erythropoietin Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Erythropoietin Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Erythropoietin Drug Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Erythropoietin Drug Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Erythropoietin Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Erythropoietin Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Erythropoietin Drug Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Erythropoietin Drug Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Erythropoietin Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Erythropoietin Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Erythropoietin Drug Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Erythropoietin Drug Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Erythropoietin Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Erythropoietin Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Erythropoietin Drug Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Erythropoietin Drug Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Erythropoietin Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Erythropoietin Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Amgen Corporation Information
    Table 108. Amgen Description and Major Businesses
    Table 109. Amgen Erythropoietin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Amgen Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Amgen Recent Developments
    Table 112. Johnson & Johnson Corporation Information
    Table 113. Johnson & Johnson Description and Major Businesses
    Table 114. Johnson & Johnson Erythropoietin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Johnson & Johnson Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Johnson & Johnson Recent Developments
    Table 117. Roche Corporation Information
    Table 118. Roche Description and Major Businesses
    Table 119. Roche Erythropoietin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Roche Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Roche Recent Developments
    Table 122. Galenica Corporation Information
    Table 123. Galenica Description and Major Businesses
    Table 124. Galenica Erythropoietin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Galenica Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Galenica Recent Developments
    Table 127. Emcure Corporation Information
    Table 128. Emcure Description and Major Businesses
    Table 129. Emcure Erythropoietin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Emcure Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Emcure Recent Developments
    Table 132. Kyowa Hakko Kirin Corporation Information
    Table 133. Kyowa Hakko Kirin Description and Major Businesses
    Table 134. Kyowa Hakko Kirin Erythropoietin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Kyowa Hakko Kirin Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Kyowa Hakko Kirin Recent Developments
    Table 137. 3SBio Corporation Information
    Table 138. 3SBio Description and Major Businesses
    Table 139. 3SBio Erythropoietin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. 3SBio Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. 3SBio Recent Developments
    Table 142. Biocon Corporation Information
    Table 143. Biocon Description and Major Businesses
    Table 144. Biocon Erythropoietin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. Biocon Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Biocon Recent Developments
    Table 147. LG Life Sciences Corporation Information
    Table 148. LG Life Sciences Description and Major Businesses
    Table 149. LG Life Sciences Erythropoietin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. LG Life Sciences Erythropoietin Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. LG Life Sciences Recent Developments
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Erythropoietin Drug Distributors List
    Table 155. Erythropoietin Drug Customers List
    Table 156. Erythropoietin Drug Market Trends
    Table 157. Erythropoietin Drug Market Drivers
    Table 158. Erythropoietin Drug Market Challenges
    Table 159. Erythropoietin Drug Market Restraints
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Erythropoietin Drug Product Picture
    Figure 3. Global Erythropoietin Drug Market Share by Type in 2021 & 2028
    Figure 3. Epoetin-alfa Product Picture
    Figure 4. Darbepoetin-alfa Product Picture
    Figure 5. Epoetin-beta Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Erythropoietin Drug Market Share by Application in 2021 & 2028
    Figure 8. Anemia
    Figure 9. Kidney Disorders
    Figure 10. Others
    Figure 11. Erythropoietin Drug Report Years Considered
    Figure 12. Global Erythropoietin Drug Sales 2017-2028 (K Units)
    Figure 13. Global Erythropoietin Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Erythropoietin Drug Revenue 2017-2028 (US$ Million)
    Figure 15. Global Erythropoietin Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Erythropoietin Drug Sales Market Share by Region (2017-2022)
    Figure 17. Global Erythropoietin Drug Sales Market Share by Region (2023-2028)
    Figure 18. North America Erythropoietin Drug Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Erythropoietin Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Erythropoietin Drug Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Erythropoietin Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Erythropoietin Drug Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Erythropoietin Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Erythropoietin Drug Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Erythropoietin Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Erythropoietin Drug Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Erythropoietin Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Erythropoietin Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Erythropoietin Drug in the World: Market Share by Erythropoietin Drug Revenue in 2021
    Figure 30. Global Erythropoietin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Erythropoietin Drug Sales Market Share by Type (2017-2028)
    Figure 32. Global Erythropoietin Drug Revenue Market Share by Type (2017-2028)
    Figure 33. Global Erythropoietin Drug Sales Market Share by Application (2017-2028)
    Figure 34. Global Erythropoietin Drug Revenue Market Share by Application (2017-2028)
    Figure 35. North America Erythropoietin Drug Sales Market Share by Type (2017-2028)
    Figure 36. North America Erythropoietin Drug Revenue Market Share by Type (2017-2028)
    Figure 37. North America Erythropoietin Drug Sales Market Share by Application (2017-2028)
    Figure 38. North America Erythropoietin Drug Revenue Market Share by Application (2017-2028)
    Figure 39. North America Erythropoietin Drug Sales Share by Country (2017-2028)
    Figure 40. North America Erythropoietin Drug Revenue Share by Country (2017-2028)
    Figure 41. U.S. Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Erythropoietin Drug Sales Market Share by Type (2017-2028)
    Figure 44. Europe Erythropoietin Drug Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Erythropoietin Drug Sales Market Share by Application (2017-2028)
    Figure 46. Europe Erythropoietin Drug Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Erythropoietin Drug Sales Share by Country (2017-2028)
    Figure 48. Europe Erythropoietin Drug Revenue Share by Country (2017-2028)
    Figure 49. Germany Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. France Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Erythropoietin Drug Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Erythropoietin Drug Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Erythropoietin Drug Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Erythropoietin Drug Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Erythropoietin Drug Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Erythropoietin Drug Revenue Share by Region (2017-2028)
    Figure 60. China Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. India Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Erythropoietin Drug Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Erythropoietin Drug Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Erythropoietin Drug Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Erythropoietin Drug Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Erythropoietin Drug Sales Share by Country (2017-2028)
    Figure 75. Latin America Erythropoietin Drug Revenue Share by Country (2017-2028)
    Figure 76. Mexico Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Erythropoietin Drug Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Erythropoietin Drug Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Erythropoietin Drug Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Erythropoietin Drug Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Erythropoietin Drug Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Erythropoietin Drug Revenue Share by Country (2017-2028)
    Figure 85. Turkey Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Erythropoietin Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. Erythropoietin Drug Value Chain
    Figure 89. Erythropoietin Drug Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed